Mitoxantrone is a sparingly soluble (0.734 mg/mL) anti-cancer agent.
|Mechanism of Action||Mitoxantrone inhibits division of T-cells, B-cells, and macrophages by preventing DNA repair and synthesis, however, this also occurs in healthy cells.|
|Cancer Applications||Mitoxantrone is commonly used against breast cancer, leukemia, and non-Hodgkin’s lymphoma.|
|Molecular Formula||C22H28N4O6 · 2 HCl|
Fox, E. J. "Mechanism of Action of Mitoxantrone." PubMed 63.12 (2004): n. pag.www.ncbi.gov. MS Clinic of Central Texas, 28 Dec. 2004. Web. 30 Aug. 2012.